CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
China National Accord Medicines Corporation Limited Company Snapshot
China National Accord Medicines Corporation Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares China National Accord Medicines Corporation Limited with three other companies in this sector in China: China National Accord Medicines Corp Ltd (2017 sales of 41.26 billion Chinese Renmimbi [US$6.01 billion] ), China National Medicines Corp., Ltd. (36.28 billion Chinese Renmimbi [US$5.28 billion] of which 98% was business department), and China Meheco Group Co Ltd (30.10 billion Chinese Renmimbi [US$4.38 billion] of which 67% was Pharmaceutical Business).

Sales Analysis. During the year ended December of 2017, sales at China National Accord Medicines Corporation Limited were 41.26 billion Chinese Renmimbi (US$6.01 billion). This is a very small increase of 0.0% versus 2016, when the company's sales were 41.24 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at China National Accord Medicines Corporation Limited (and since 2012, sales have increased a total of 129%). Sales of Retail saw an increase that was more than double the company's growth rate: sales were up 10.1% in 2017, from 9.11 billion Chinese Renmimbi to 10.03 billion Chinese Renmimbi. China National Accord Medicines Corporation Limited also saw significant increases in sales in Distribution (up 0.3% to 31.23 billion Chinese Renmimbi) . Not all segments of China National Accord Medicines Corporation Limited experienced an increase in sales in 2017: sales of Headquarters fell 71.0% to 7.02 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
China National Accord Medicines Corporation Limited
  Stock Performance Chart for China National Accord Medicines Corporation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/14/2018): 25.02
(Figures in Chinese Renmimbi)
1 Week -5.2%   13 Weeks 0.2%  
4 Weeks -7.0%   52 Weeks -27.1%  
 
China National Accord Medicines Corporation Limited Key Data:
  Ticker: 200028 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 41,263,629,119
(Year Ending Jan 2018).
Employees: 22,480
  Currency: Chinese Renmimbi Market Cap: 10,711,480,238
  Fiscal Yr Ends: December Shares Outstanding: 428,126,983
  Share Type: B Gu Closely Held Shares: 255,220,339
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.